SEC Filings | Y-mAbs Therapeutics, Inc.

Filing date	Description	Form	Filing Group	View
May 05, 2023	EFFECT	EFFECT	Other	9999999995-23-001320.pdf 9999999995-23-001320.rtf 9999999995-23-001320.xls View HTML
May 02, 2023	CORRESP	CORRESP	Other	0001104659-23-055096.pdf 0001104659-23-055096.rtf 0001104659-23-055096.xls View HTML
Apr 28, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	Proxy Filings	0001104659-23-051900.pdf 0001104659-23-051900.rtf 0001104659-23-051900.xls View HTML
Apr 28, 2023	Additional proxy soliciting materials - definitive	DEFA14A	Proxy Filings	0001104659-23-051910.pdf 0001104659-23-051910.rtf View HTML
Apr 28, 2023	An annual report to security holders	ARS	Annual Filings	0001104659-23-051919.pdf 0001104659-23-051919.rtf View HTML
Apr 18, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	0001104659-23-046465.pdf 0001104659-23-046465.rtf 0001104659-23-046465.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 05, 2023	Report of unscheduled material events or corporate event	8-K	Current Reports	0001104659-23-041911.pdf 0001104659-23-041911.rtf 0001104659-23-041911.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 03, 2023	A statement of beneficial ownership of common stock by certain persons	SC 13G	Other	0000902664-23-002445.pdf 0000902664-23-002445.rtf 0000902664-23-002445.xls View HTML
Apr 03, 2023	UPLOAD	UPLOAD	Other	0000000000-23-003334.pdf 0000000000-23-003334.rtf View HTML
Mar 30, 2023	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	0001558370-23-005073.pdf 0001558370-23-005073.rtf 0001558370-23-005073.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.